Search
Returning search results with filters:
Remove filter for
Last updated: 2005
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 7 of 7 items.
Archived - Important Safety Information on IRESSA® (gefitinib) 250 mg Tablets - AstraZeneca Canada Inc.
AlertInformation update | 2005-08-26
Important Safety Information on Oxeze (formoterol fumarate dihydrate) Turbuhaler – AstraZeneca Canada Inc. – For Health Professionals
AlertHealth professional risk communication | 2005-09-09
Association of CRESTOR® (rosuvastatin) with Muscle -Related Adverse Events – AstraZeneca Canada Inc. – For Health Professionals
AlertHealth professional risk communication | 2005-03-11
Iressa (gefitinib) 250 mg Tablets - Advisories, Warnings and Recalls for Health Professionals
AlertHealth professional risk communication | 2005-08-26
Archived - Association of CRESTOR
AlertHealth professional risk communication | 2005-03-08
Archive - Safety Information about a Class of Asthma Drugs Known as Long-Acting Beta-2 Agonists
AlertPublic advisory | 2005-10-04
Archived – Health Canada advises patients about the risks of CRESTOR® (rosuvastatin)
AlertPublic advisory | 2005-03-03